Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 123–132Open access
Antidepressant Potential of Albizzia lebbeck SLNs
- 1,
- 2*
- 1 Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B G Nagar, Karnataka, INDIA.
- 2 Department of pharmacology, NITEE College of Pharmaceutical Sciences, Bangalore, Karnataka, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Mohammad Ali
Department of pharmacology, NITEE College of Pharmaceutical Sciences, Bangalore, Karnataka, INDIA.
Email: alimohammad973@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- May 8, 2025
- Accepted:
- Sep 12, 2025
- DOI:
- 10.5530/ijpi.20260573
How to cite
Kavitha, S. K., & Ali, M. (2026). Antidepressant Potential of Albizzia lebbeck SLNs. International Journal of Pharmaceutical Investigation, 16(1), 123–132. https://doi.org/10.5530/ijpi.20260573
Abstract
Background
To assess in vivo antidepressant of Ethanolic extract of Albizzia lebbeck (L.) own their family Fabaceae the plant's primary constituents Triterpenes, glycosides, saponins, flavonoids, and indole alkaloids are the main components of Albizzia lebbeck (L.), a member of the Fabaceae family, which is used to evaluate the in vivo antidepressant properties of its ethanolic extract. Reports on the pharmacological effects of anti-inflammatory, antioxidant, cytotoxic, anti-genotoxic, sedative and antiepileptic, anti-convulsant, anti-helminthic, anti-microbial, anti-fungal, and antipyretic substances can be found in the literature review. It has been reported that Albizzia lebbeck has anti-epileptic properties. Thus,
Materials and Methods
The current study is intended to have antidepressant effects on test animals. The impact of an Alzzia lebbeck (L.) leaf ethanol extract on Swiss albino mice's depression: For 21 days in a row, Swiss albino mice were repeatedly exposed to moderate stress. For 21 days, various groups of stressed and unstressed mice received oral doses of imipramine (15 mg/kg) and EEAL (200 and 400 mg/kg). The Open Field Test (OFT) and the Tail Suspension Test (TST) were performed locomotory one hour after the mice were given oral doses of 200 or 400 mg/kg of EEAL&ASLNs to assess their inclination toward depressive-like behavior.
Results
After receiving EEAL (200 mg/kg), ASLNs (100, 200, 400 mg/kg), and imipramine (15 mg/kg) for 21 days, the immobility duration of both stressed and unstressed mice was significantly reduced. Both TST and OFT showed the previously mentioned effect. Albizzia lebbeck (L.) ethanol leaf extract dramatically raised catalase levels while lowering MDA levels. After being treated with EEAL (200 mg/kg) and ASLNs, the serotonin levels of both calm and nervous mice significantly increased compared to their vehicle-treated counterparts.
Conclusion
The ASLNs demonstrated potent antidepressant-like effects in both stressed and relaxed mice, possibly lowering oxidative stress.
Keywords
Subject
Article metadata
| Title | Antidepressant Potential of Albizzia lebbeck SLNs |
|---|---|
| Authors | S K Kavitha; Mohammad Ali |
| Affiliations | Department of Pharmacology, Faculty of Pharmacy, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B G Nagar, Karnataka, INDIA.; Department of pharmacology, NITEE College of Pharmaceutical Sciences, Bangalore, Karnataka, INDIA. |
| Corresponding author | alimohammad973@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50